insulin icodec 700 U/mL PDS290, Semaglutide B 1.34 mg/ml PDS290 clinical trials

A single arm study investigating the glycaemic control and safety of adding semaglutide to insulin icodec in participants with type 2 diabetes qualifying for treatment intensification.

This study looks at how well a new combination of medicines, semaglutide and insulin icodec, works for people with type 2 diabetes. It checks if this combination helps control blood sugar levels and if it's safe to use when current treatments aren't enough.